Enochian BioSciences announces Scientific Presentation of a

Enochian BioSciences announces Scientific Presentation of a

News Highlights

LOS ANGELES, May 12, 2021 (News) — (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the release of preliminary data relating to the use of a novel cell therapy approach in controlling human immunodeficiency virus (HIV) in humans. Dr. Serhat Gumrukçu, co-founder and inventor of Enochian BioSciences and Director of the Seraph Research Institute (SRI), presented the findings at the Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). Presentation can be found at https://www.enochianbio.com/about-us/collaborations/

A 54-year-old man, diagnosed with HIV in 1986, had persistent HIV detected in his blood, despite antiretroviral therapy. With approval from an Institutional Review Board, this single patient was treated with a novel cellular therapy of natural killer (NK) and gamma delta T-cells (GDT) – a small subset of immune cells that can be infected with HIV but could also be a key factor in controlling the virus. The NK and GDT cells were collected from a person who does not have HIV. Because the patient stopped antiviral treatment and received some supportive medication before the cellular therapy, the level of HIV initially increased, as expected.

However, HIV levels began to decline after approximately three weeks, and after 100 days dropped below the detection level of routinely used blood tests (20 copies/ml). HIV levels in the patient’s blood have remained at or below detection for an additional 255 days, all while the patient has not been taking antiviral medication.

This innovative cell therapy could be a potential strategy to achieve a “functional cure” for HIV. This could potentially allow persons living with HIV to stop antiviral treatment for extended periods of time. Dr. Gumrukçu and SRI are currently pursuing a regulatory pathway with the FDA to study the approach in more patients. Enochian BioSciences holds the exclusive license for the proprietary technology.

Dr. Mark Dybul, a prominent global HIV expert and Executive Vice Chair of Enochian BioSciences said, “As an HIV researcher, clinician and former leader of large, global HIV treatment programs, I am excited by these results. Although antiviral treatment is very effective, it is expensive and some patients cannot, or do not want to receive it. This, combined with the fact that access to antiviral treatments is limited, creates a significant unmet medical need. While the findings presented are preliminary and in one person with HIV, I’m hopeful that with further testing in larger patient populations, SRI’s novel cell therapy approach could one day be an alternative HIV treatment to many.”

About Enochian BioSciences, Inc.Enochian BioSciences, Inc. is a biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. The company’s gene-modified cell therapy platform can be applied to multiple indications, including HIV/AIDS and Oncology. For more information, please visit www.enochianbio.com

About Seraph Research Institute (SRI)Seraph Research Institute is a Los Angeles-based non-profit research institution, which runs basic science, translational and clinical research in pursuit of cures and effective treatments for chronic viral infections, cancers, and genetic disorders. For more information, please visit Seraphinstitute.org

Forward-Looking StatementsStatements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Enochian BioSciences’ most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The findings in this press release are preliminary and based on one person. There is no assurance the findings will result in an effective alternative treatment for HIV. All forward-looking statements are qualified in their entirety by this cautionary statement, and Enochian BioSciences undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

  • Check the latest Health news updates and information.
  • Please share this news Enochian BioSciences announces Scientific Presentation of a with your friends and family to support us your one share helps us a lot.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
New  News Lured to College Station as Economy Rises |  News

New News Lured to College Station as Economy Rises | News

“I think it will be a big hit with students,” Vasquez said. “If anybody wants some late night cookies, they can go there or have them delivered, which is ...
These investment mistakes will cost you money

At the G-7 Summit, world leaders must commit to increasing climate finance for developing countries

On international climate finance, specifically, the text stated: However, in terms of climate outcomes, the Finance Ministers’ Communique was disappointing. ...
Stimulus money may start to reach your bank account AUTOMATICALLY as calls increase for a fourth round of relief checks

Stimulus money may start to reach your bank account AUTOMATICALLY as calls increase for a fourth round of relief checks

“We’ll see what members of Congress propose, but those are not free,” said Psaki. However, White House Press Secretary Jen Psaki recently warned another round ...
Recap of Windows 11 Rumors & More

Recap of Windows 11 Rumors & More

As is the specialty on this podcast, there also was our Fast Recap and our Week Ahead segments. In Fast recap, we covered Microsoft’s Experience Centers ...
Back 4 Blood coming to Xbox Game Pass at launch on Oct 12

Back 4 Blood coming to Xbox Game Pass at launch on Oct 12

The new trailer for the co-op zombie shooter revealed during the Xbox and Bethesda E3 showcase also announced new swamp and PvP modes. Those who want to ...
Musk says Tesla has sold about 10% of bitcoin to test the market and will ‘retake permission for cryptographic transactions’ when 50% of miners go green

Musk says Tesla has sold about 10% of bitcoin to test the market and will ‘retake permission for cryptographic transactions’ when 50% of miners go green

Back in February, Tesla revealed that it acquired some $1.5 billion in bitcoin in a filing with the Securities and Exchange Commission. At last check Sunday ...
More money sought by local health councils |  local news

More money sought by local health councils | local news

Allen said there is also a need for better communication and cooperation between local officials and federal and state agencies, which weren’t always on the ...
Kaboxer, a tool for managing programmes in containers, is released by the Kali Linux team

With Linux 5.14, XFS will see a significant increase in scalability

The message on the merge further explains the code that’s been reworked in the XFS driver for better scalability around the CIl and log: The log write ...
Breaking News:Helping Kids Start Investing Makes a Great Father’s Day Gift |  local news

Breaking News:Helping Kids Start Investing Makes a Great Father’s Day Gift | local news

Source statesville.com An IRA is a great introduction to the world of investing. For one thing, your child can make small contributions throughout the ...
How about 'Monkey Business' in Clinton?

Heaven Hill Distillery to Unveil Renovated and Expanded Heritage Center | The business

Copyright 2021 WDRB Media. All Rights Reserved. Related Stories: Source www.wdrb.com “People are becoming so much more educated and aware of the bourbon ...
Show next
Compsmag - Latest News from tech, business and health
Logo